TPC2-A1-N is a potent agonist of the Ca²⁺-permeable two-pore channel 2 (TPC2), mimicking the physiological effects of NAADP; it induces robust TPC2-mediated Ca²⁺ responses (EC₅₀ = 7.8 μM), which can be selectively blocked by TPC inhibitors such as Tetrandrine, Raloxifene, and Fluphenazine; it is used to probe distinct functional roles of TPC2 channels in intact cells; TPC2-A1-N evokes Ca²⁺ influx through the TPC2 pore and elicits currents with Na⁺ as the major permeant ion in endo-lysosomal patch-clamp experiments; it shows enhanced activity on gain-of-function TPC2 variants (e.g., TPC2-M484L) with an EC₅₀ of 0.6 μM.